Patrocinado

Emcure stake buy: Pharma firm to acquire 20.42% in Zuventus for Rs 724.9 crore; full ownership to aid consolidation

Emcure Pharmaceuticals will acquire the remaining 20.42% stake in Zuventus Healthcare for ₹724.9 crore, making it a wholly-owned subsidiary. The board has approved the acquisition from minority shareholders, with the transaction expected to close in the September quarter of FY26.
Pesquisar
Categorias
Leia mais
Sunshine, smiles, and playtime magic at Ratna Park (Pics)
KATHMANDU: Ratnapark, located at the heart of the city near Ratna Batika, remains one of the few...
Por HamroGlobal 0 6
When Genelia D'Souza let her jhumkas do the talking
From traditional gold pieces to modern oxidized styles, Genelia Deshmukh’s picks perfectly...
Por BharatUpdates 0 9
'You started it, we will end it': Iran media warns Donald Trump after strikes on nuclear sites; airs map of US military bases in Middle East
Tensions escalate as Iranian State TV threatens retaliation following US strikes on Iran's...
Por BharatUpdates 0 28
'The bully must now make peace': What Trump said after Iran strike; top quotes
President Trump announced US military strikes on Iran's nuclear facilities, citing the need to...
Por BharatUpdates 0 28
Sourav Ganguly warns Shubman Gill - 'India won't get ...'
Sourav Ganguly wants India to secure victory in the first Test match against England. India...
Por BharatUpdates 0 31